Nice find...It looks like they may have shareholders with the deep pockets to fund a prospective US PCT for FDA approval also !
Therefore, one key advantage of Amadix is ourinvestors’ confidence. Amadix has been supported from the beginning by some of the most solidventure capital fundsin Spain, some of which are specialized in biotechnology and medical devices, such as CRB Inverbio, Inveready, Clave Mayor, Alentia, ADE Capital Sodical and INNVIERTE (CDTI). They have in-depth knowledge about the in vitro diagnostics (IVD) market and give us financial and business development support.
RHY Price at posting:
10.5¢ Sentiment: None Disclosure: Not Held
